Dove Clinical Protection
Natural health product licensed in Canada
- Licence holder
- Unilever Canada Inc., Division of Unilever Inc.
- NPN or DIN-HM
- 80008014
- Status
- Inactive licence
- Licence date
- 9 October 2008
- Revision date
- Not provided
- Form
- Bâtonnet
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
silice, Cyclopentasiloxane, Polymère sequencé de diméthicone, Wax, Microcyrstalline, Diméthicone, BHT, C18-36 acid triglycerides, Huile de graines d'Helianthus Annus (tournesol), Parfum
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | 2 Solide | Not specified |
Uses authorised in Canada
Antiperspirant. Provides clinically proven extra effective protection against wetness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not apply on broken skin.
Source
Official Health Canada record, licence 80008014
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.